416 related articles for article (PubMed ID: 28861504)
1. Cannabinoid CB
Ibsen MS; Connor M; Glass M
Cannabis Cannabinoid Res; 2017; 2(1):48-60. PubMed ID: 28861504
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence.
Ibsen MS; Finlay DB; Patel M; Javitch JA; Glass M; Grimsey NL
Front Pharmacol; 2019; 10():350. PubMed ID: 31024316
[TBL] [Abstract][Full Text] [Related]
4. Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists.
Wouters E; Walraed J; Banister SD; Stove CP
Biochem Pharmacol; 2019 Nov; 169():113623. PubMed ID: 31472128
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol skews biased agonism at cannabinoid CB
Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
[TBL] [Abstract][Full Text] [Related]
6. 7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands.
Penthala NR; Shoeib A; Dachavaram SS; Cabanlong CV; Yang J; Zhan CG; Prather PL; Crooks PA
Bioorg Med Chem Lett; 2020 Nov; 30(22):127501. PubMed ID: 32882418
[TBL] [Abstract][Full Text] [Related]
7. Functional Selectivity at Cannabinoid Receptors.
Priestley R; Glass M; Kendall D
Adv Pharmacol; 2017; 80():207-221. PubMed ID: 28826535
[TBL] [Abstract][Full Text] [Related]
8. Similarities and differences upon binding of naturally occurring Δ
Raïch I; Rivas-Santisteban R; Lillo A; Lillo J; Reyes-Resina I; Nadal X; Ferreiro-Vera C; de Medina VS; Majellaro M; Sotelo E; Navarro G; Franco R
Pharmacol Res; 2021 Dec; 174():105970. PubMed ID: 34758399
[TBL] [Abstract][Full Text] [Related]
9. Absence of Entourage: Terpenoids Commonly Found in
Santiago M; Sachdev S; Arnold JC; McGregor IS; Connor M
Cannabis Cannabinoid Res; 2019; 4(3):165-176. PubMed ID: 31559333
[No Abstract] [Full Text] [Related]
10. New Insights in Cannabinoid Receptor Structure and Signaling.
Ye L; Cao Z; Wang W; Zhou N
Curr Mol Pharmacol; 2019; 12(3):239-248. PubMed ID: 30767756
[TBL] [Abstract][Full Text] [Related]
11. Protocol to Study β-Arrestin Recruitment by CB1 and CB2 Cannabinoid Receptors.
Soethoudt M; van Gils N; van der Stelt M; Heitman LH
Methods Mol Biol; 2016; 1412():103-11. PubMed ID: 27245896
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological actions of cannabinoids.
Pertwee RG
Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
[TBL] [Abstract][Full Text] [Related]
13. Prediction of the Binding Affinities and Selectivity for CB1 and CB2 Ligands Using Homology Modeling, Molecular Docking, Molecular Dynamics Simulations, and MM-PBSA Binding Free Energy Calculations.
Ji B; Liu S; He X; Man VH; Xie XQ; Wang J
ACS Chem Neurosci; 2020 Apr; 11(8):1139-1158. PubMed ID: 32196303
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid CB
Olianas MC; Dedoni S; Onali P
Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
[TBL] [Abstract][Full Text] [Related]
15. CB1 Cannabinoid Receptor Signaling and Biased Signaling.
Leo LM; Abood ME
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500853
[TBL] [Abstract][Full Text] [Related]
16. Structural Insights into CB1 Receptor Biased Signaling.
Al-Zoubi R; Morales P; Reggio PH
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013934
[TBL] [Abstract][Full Text] [Related]
17. Methods to Quantify Cell Signaling and GPCR Receptor Ligand Bias: Characterization of Drugs that Target the Endocannabinoid Receptors in Huntington's Disease.
Bagher AM; Laprairie RB; Kelly MEM; Denovan-Wright EM
Methods Mol Biol; 2018; 1780():549-571. PubMed ID: 29856035
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
Ashton JC; Wright JL; McPartland JM; Tyndall JD
Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias.
Manning JJ; Green HM; Glass M; Finlay DB
Neuropharmacology; 2021 Aug; 193():108611. PubMed ID: 34000272
[TBL] [Abstract][Full Text] [Related]
20. Two Janus Cannabinoids That Are Both CB2 Agonists and CB1 Antagonists.
Dhopeshwarkar A; Murataeva N; Makriyannis A; Straiker A; Mackie K
J Pharmacol Exp Ther; 2017 Feb; 360(2):300-311. PubMed ID: 27927913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]